IL105349A0 - Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof - Google Patents
Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereofInfo
- Publication number
- IL105349A0 IL105349A0 IL105349A IL10534993A IL105349A0 IL 105349 A0 IL105349 A0 IL 105349A0 IL 105349 A IL105349 A IL 105349A IL 10534993 A IL10534993 A IL 10534993A IL 105349 A0 IL105349 A0 IL 105349A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- carbolines
- compounds
- methods
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4212529A DE4212529A1 (en) | 1992-04-10 | 1992-04-10 | Use of µ-carbolines as non-competitive glutamate antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL105349A0 true IL105349A0 (en) | 1993-08-18 |
Family
ID=6456829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105349A IL105349A0 (en) | 1992-04-10 | 1993-04-09 | Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0633779A1 (en) |
| JP (1) | JPH07505404A (en) |
| KR (1) | KR950700739A (en) |
| CA (1) | CA2117755A1 (en) |
| DE (1) | DE4212529A1 (en) |
| FI (1) | FI944714A (en) |
| HU (1) | HUT68212A (en) |
| IL (1) | IL105349A0 (en) |
| WO (1) | WO1993020820A1 (en) |
| ZA (1) | ZA932553B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330175A1 (en) * | 1993-08-31 | 1995-03-02 | Schering Ag | Alkoxy substituted beta carbolines |
| DE4436190A1 (en) * | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenated β-carboline derivatives, process for their preparation and use of these substances for inhibiting the respiratory chain |
| RU2106864C1 (en) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | New approach to treatment of alzheimer's disease |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| PL332413A1 (en) | 1996-09-27 | 1999-09-13 | Guilford Pharm Inc | Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals |
| CA2610956A1 (en) * | 2005-06-06 | 2006-12-14 | Fibrogen, Inc. | Improved treatment for anemia using a hif-alpha stabilising agent |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3540653A1 (en) * | 1985-11-13 | 1987-05-14 | Schering Ag | NEW 3-OXADIAZOLE AND 3-CARBONIC ACID SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
| DE3545776A1 (en) * | 1985-12-20 | 1987-06-25 | Schering Ag | 5-AMINOALKYL-SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
-
1992
- 1992-04-10 DE DE4212529A patent/DE4212529A1/en not_active Withdrawn
-
1993
- 1993-04-06 WO PCT/EP1993/000858 patent/WO1993020820A1/en not_active Application Discontinuation
- 1993-04-06 EP EP93908924A patent/EP0633779A1/en not_active Withdrawn
- 1993-04-06 CA CA002117755A patent/CA2117755A1/en not_active Abandoned
- 1993-04-06 JP JP5517954A patent/JPH07505404A/en active Pending
- 1993-04-06 HU HU9402925A patent/HUT68212A/en unknown
- 1993-04-08 ZA ZA932553A patent/ZA932553B/en unknown
- 1993-04-09 IL IL105349A patent/IL105349A0/en unknown
-
1994
- 1994-10-07 FI FI944714A patent/FI944714A/en not_active Application Discontinuation
- 1994-10-08 KR KR1019940703566A patent/KR950700739A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR950700739A (en) | 1995-02-20 |
| ZA932553B (en) | 1993-11-02 |
| WO1993020820A1 (en) | 1993-10-28 |
| HUT68212A (en) | 1995-06-28 |
| EP0633779A1 (en) | 1995-01-18 |
| CA2117755A1 (en) | 1993-10-11 |
| FI944714A0 (en) | 1994-10-07 |
| JPH07505404A (en) | 1995-06-15 |
| FI944714A (en) | 1994-10-07 |
| DE4212529A1 (en) | 1993-10-14 |
| HU9402925D0 (en) | 1995-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL108873A0 (en) | 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof | |
| HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| IL106600A0 (en) | Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof | |
| IL107978A0 (en) | Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL112193A0 (en) | Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL89702A0 (en) | Water soluble ibuprofen compositions,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL98873A0 (en) | Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL91361A0 (en) | Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL105348A0 (en) | Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL92425A0 (en) | Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
| ZA929883B (en) | Pharmaceutical composition and process for the preparation thereof | |
| IL88903A0 (en) | Indolylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ZA955781B (en) | New chemical compound the preparation thereof and its use in pharmaceutical compositions | |
| IL103151A0 (en) | Beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GB2245890B (en) | Basic aluminium antiperspirant active materials, antiperspirant active compositions comprising the same and methods for the preparation thereof | |
| IL107358A0 (en) | a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| IL115272A0 (en) | Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof | |
| IL92268A0 (en) | 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ZA941088B (en) | Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them | |
| IL105349A0 (en) | Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof | |
| IL102116A0 (en) | Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
| IL107808A0 (en) | Diarylalkane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| IL102027A0 (en) | Cephem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
| IL115981A (en) | Cyclolignan derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL95088A0 (en) | Pyrroloquinoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |